Preclinical In vivo Imaging Market
Preclinical In vivo Imaging Market Size, Share & Industry Analysis, By Modality (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-Ultrasound, Photoacoustic Imaging), By Application (Oncology, Neurology, Cardiology, Inflammation, Infectious Diseases, Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) -- Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
The global Preclinical In vivo Imaging market is expected to grow at a CAGR of XX% during the forecast period (2024-2031), reaching a value of USD YY billion by 2031, up from USD XX billion in 2024. North America is expected to dominate the market throughout the forecast period. The growth of the Preclinical In vivo Imaging market is driven by the increasing demand for non-invasive imaging techniques in drug discovery and development, the growing prevalence of chronic diseases, and advancements in imaging technologies.
Preclinical In vivo Imaging Market Dynamics:
Growing demand for non-invasive imaging techniques in drug discovery and development
Preclinical in vivo imaging is important for drug discovery and development because it enables the real-time, non-invasive visualisation and quantification of biological processes in living animals. These imaging techniques help researchers determine the safety, efficacy, and pharmacokinetics of drug candidates, reducing the time and cost associated with drug development. The global pharmaceutical R&D investment is predicted to exceed USD 200 billion by 2023, with preclinical research accounting for a sizable portion.
Technological advancements in imaging modalities
Continuous advancements in imaging technologies, such as high-resolution optical imaging, multi-modal imaging, and AI-based image processing, are driving the Preclinical In vivo Imaging market. These improvements enable researchers to obtain more accurate, complete, and quantitative data from preclinical studies, hence improving the quality and repeatability of study findings. PerkinElmer, for example, developed a new multi-modal preclinical imaging system in January 2024 that can image with optical, X-ray, and nuclear technologies.
High cost of preclinical imaging systems
The high cost of preclinical imaging systems may limit market growth, particularly among small and medium-sized pharmaceutical businesses and academic research institutions. Preclinical imaging systems can range in price from USD 200,000 to over USD 1 million, depending on the modality and features. However, the increasing usage of shared imaging facilities, as well as the emergence of low-cost, compact imaging devices, are expected to remove some of these constraints.
Segment Overview
By Modality, the Optical Imaging segment is expected to dominate the market during the forecast period.
Optical imaging, which includes techniques such as bioluminescence and fluorescence imaging, is widely used in preclinical research due to its high sensitivity, specificity, and cost effectiveness. The increasing availability of genetically engineered animal models and fluorescent probes has accelerated the use of optical imaging in preclinical research. Preclinical applications made up a sizable portion of the global optical imaging market in 2023, which was valued at USD 1.8 billion.
Regional Outlook:
North America is expected to dominate the Preclinical In vivo Imaging market during the forecast period.
North America's dominant position in the Preclinical In vivo Imaging market may be attributed to a variety of factors, including the presence of major pharmaceutical and biotechnology companies, well-established research infrastructure, and significant investments in drug discovery and development. The region's excellent regulatory structure, combined with a rising emphasis on customised medicine, is driving market growth. In 2023, the United States led the North American Preclinical In vivo Imaging market, followed by Canada.
Recent market developments in North America include:
-
August 2023 and MR Solutions launching a compact, helium-free preclinical MRI system in October 2023, both of which address the region's growing demand for space-efficient imaging solutions.
-
In 2023, North America accounted for YY% of the global Preclinical In vivo Imaging market. The United States accounted for YY% of the North American market.
Competitive Intelligence:
The Preclinical In vivo Imaging market is highly competitive, with several significant competitors focussing on product innovation, technological advancements, and strategic alliances. Major market participants include PerkinElmer, Bruker Corporation, FUJIFILM VisualSonics, Mediso Ltd., MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences, and Trifoil Imaging.
PerkinElmer is the global leader in preclinical in vivo imaging, offering a wide range of imaging instruments and software solutions. The company's IVIS line of optical imaging equipment and Quantum GX2 microCT system have been well received in the market, allowing it to maintain its dominant position.
Recent developments in the competitive landscape include:
-
In March 2024, FUJIFILM VisualSonics announced a partnership with a pharmaceutical business to create AI-powered preclinical ultrasound imaging tools for drug discovery.
-
To boost its position in the European market, Mediso Ltd. will launch a new preclinical PET/CT imaging equipment with increased sensitivity and resolution in June 2024.
The Preclinical In vivo Imaging market is predicted to grow in the next years due to the increasing demand for non-invasive imaging techniques in drug discovery and development, rising chronic illness prevalence, and ongoing technological advancements. As the market evolves, companies who offer new, integrated, and cost-effective preclinical imaging solutions will gain a competitive advantage.
Major Players:
-
PerkinElmer
-
Bruker Corporation
-
FUJIFILM VisualSonics
-
Mediso Ltd.
-
MILabs B.V.
-
MR Solutions
-
Aspect Imaging
-
LI-COR Biosciences
-
Trifoil Imaging
Key Developments:
-
August 2023: Bruker Corporation acquires a preclinical imaging software firm.
-
In March 2024, FUJIFILM VisualSonics and a leading pharmaceutical business announced a partnership to create AI-powered preclinical ultrasound imaging products.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)*
5. COMPANY PROFILES
5.1. PerkinElmer
5.2. Bruker Corporation
5.3. FUJIFILM VisualSonics
5.4. Mediso Ltd.
5.5. MILabs B.V.
5.6. MR Solutions
5.7. Aspect Imaging
5.8. LI-COR Biosciences
5.9. Trifoil Imaging
5.10. Miltenyi Biotec (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Growing demand for non-invasive imaging techniques in drug discovery and development
6.1.2. Technological advancements in imaging modalities
6.1.3. Increasing adoption of multimodal imaging approaches
6.2. Market Drivers
6.2.1. Rising prevalence of chronic diseases
6.2.2. Growing investments in pharmaceutical R&D
6.2.3. Increasing focus on personalized medicine
6.3. Market Restraints
6.3.1. High cost of preclinical imaging systems
6.3.2. Stringent regulations for animal research
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY MODALITY (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Optical Imaging
7.1.1. Bioluminescence Imaging
7.1.2. Fluorescence Imaging
7.1.3. Optoacoustic Imaging
7.2. Nuclear Imaging
7.2.1. Positron Emission Tomography (PET)
7.2.2. Single-Photon Emission Computed Tomography (SPECT)
7.3. Micro-MRI
7.3.1. Anatomical Imaging
7.3.2. Functional Imaging
7.4. Micro-CT
7.4.1. In vivo Micro-CT
7.4.2. Ex vivo Micro-CT
7.5. Micro-Ultrasound
7.5.1. Anatomical Imaging
7.5.2. Functional Imaging
7.5.3. Molecular Imaging
7.6. Photoacoustic Imaging
7.6.1. Anatomical Imaging
7.6.2. Functional Imaging
7.6.3. Molecular Imaging
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Oncology
8.1.1. Tumor Monitoring
8.1.2. Metastasis Detection
8.1.3. Therapy Response Assessment
8.2. Neurology
8.2.1. Neurodegenerative Diseases
8.2.2. Neurological Disorders
8.2.3. Brain Injury
8.3. Cardiology
8.3.1. Cardiovascular Diseases
8.3.2. Cardiac Function Assessment
8.4. Inflammation
8.4.1. Inflammatory Diseases
8.4.2. Immune System Monitoring
8.5. Infectious Diseases
8.5.1. Bacterial Infections
8.5.2. Viral Infections
8.6. Others
8.6.1. Reproductive Disorders
8.6.2. Metabolic Disorders
9. BY END-USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Pharmaceutical & Biotechnology Companies
9.1.1. Large Enterprises
9.1.2. Small & Medium Enterprises
9.2. Contract Research Organizations
9.2.1. Large CROs
9.2.2. Small & Medium CROs
9.3. Academic & Research Institutes
9.3.1. Universities
9.3.2. Research Centers
9.3.3. Government Institutions
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Modality:
-
Optical Imaging
-
Nuclear Imaging
-
Micro-MRI
-
Micro-CT
-
Micro-Ultrasound
-
Photoacoustic Imaging
By Application:
-
Oncology
-
Neurology
-
Cardiology
-
Inflammation
-
Infectious Diseases
-
Others
By End-User:
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations
-
Academic & Research Institutes
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511